0.05% Voclosporin Ophthalmic Solution (VOS)
AUR-VOS-2019-01
Phase 3 small_molecule completed
Quick answer
0.05% Voclosporin Ophthalmic Solution (VOS) for Dry Eye Syndrome is a Phase 3 program (small_molecule) at Aurinia Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Aurinia Pharmaceuticals
- Indication
- Dry Eye Syndrome
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed